Back to Search Start Over

A first: FDA approves drug to treat agitation in Alzheimer’s

Authors :
Lasek, Alicia
Source :
McKnight's Long-Term Care News. July 11, 2023
Publication Year :
2023

Abstract

The Food and Drug Administration in May approved the first drug to treat agitation related to Alzheimer’s disease dementia. Patient advocates hailed the news, but prescribing the drug, an antipsychotic, [...]

Subjects

Subjects :
United States. Food and Drug Administration
Alzheimer's disease -- Drug therapy
Drug approval
Business
Health
Health care industry
Seniors
Rexulti (Medication)

Details

Language :
English
ISSN :
10483314
Database :
Gale General OneFile
Journal :
McKnight's Long-Term Care News
Publication Type :
Periodical
Accession number :
edsgcl.756707260

Tools

Authors Abstract Subjects Details